HUM Relative Valuation
HUM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HUM is overvalued; if below, it's undervalued.
Historical Valuation
Humana Inc (HUM) is now in the Undervalued zone, suggesting that its current forward PE ratio of 15.56 is considered Undervalued compared with the five-year average of 19.61. The fair price of Humana Inc (HUM) is between 250.41 to 328.49 according to relative valuation methord. Compared to the current price of 224.93 USD , Humana Inc is Undervalued By 10.18%.
Relative Value
Fair Zone
250.41-328.49
Current Price：224.93
10.18%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.62
P/B
Median3y
3.11
Median5y
3.33
8.29
FCF Yield
Median3y
3.81
Median5y
4.54
Competitors Valuation Multiple
The average P/S ratio for HUM's competitors is 0.49, providing a benchmark for relative valuation. Humana Inc Corp (HUM) exhibits a P/S ratio of 0.22, which is -53.90% above the industry average. Given its robust revenue growth of 8.45%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Humana Inc (HUM) currently overvalued or undervalued?
What is Humana Inc (HUM) fair value?
How does HUM's valuation metrics compare to the industry average?
What is the current P/B ratio for Humana Inc (HUM) as of May 24 2025?
What is the current FCF Yield for Humana Inc (HUM) as of May 24 2025?
What is the current Forward P/E ratio for Humana Inc (HUM) as of May 24 2025?